San Mateo
-
With New Kind of CAR, Cancer Startup Cargo Refuels With $200M for Cell Therapy Race
Cargo Therapeutics is developing CAR T-cell therapies that overcome ways cancers evade currently available treatments. True to its name, the startup’s approach involves putting more cargo and more complex cargo onto engineered T cells.
-
Scripps Spinout Belharra Unveils $130M to Catch Next Big Wave of Drug Discovery
Versant Ventures-backed Belharra Therapeutics has launched with $130 million in funding and a partnership with Roche subsidiary Genentech. The startup’s technology analyzes proteins in the context of the entire cell, enabling it to discover molecules that bind to targets previously deemed undruggable.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Sierra succeeds where Gilead missed; FDA filing now planned for blood cancer drug
Sierra Oncology myelofibrosis drug momelotinib achieved the main and secondary goals of a pivotal test and the biotech now plans to seek FDA approval. Sierra acquired momelotinib from Gilead Sciences after that company stopped work on the drug due to mixed results in Phase 3 testing.
-
Evidation plans to launch virtual health programs with $153M in new funding
Evidation, launched as a research app where people can opt into virtual clinical trials, now plans to offer digital health programs. The company recently raised $153 million in new funding.
-
Human API raises $20 million to bring health records into one place
Human API, a startup making it easier for consumers to share their health data, raised $20 million in funding. The company plans to use the funds to build out new features for clinical trial recruitment, insurance and digital health
-
Kronos Bio raises $155M in private financing to advance lead leukemia drug into registration study next year
The company has raised $148 million so far and plans to raise the remaining $7 million by next month. Its lead candidate is entospletinib, a SYK inhibitor acquired as part of a deal with Gilead Sciences last month, under development for patients with biomarker-defined acute myeloid leukemia.
-
Startups talk about what it’s like to raise money in a pandemic
MedCity spoke with Evidation and BrightInsight, two startups that have recently announced funding rounds, amid a Covid-19 pandemic worsening in the U.S.
-
Helix, Mayo Clinic embark on genomic sequencing study of 100,000 people
The Rochester, Minnesota-based healthcare system and San Mateo, California-based population genomics company plan to launch the study in the next few weeks.
-
Kronos Bio bags $105M in Series A round for platform technology
The company, led by a Gilead Sciences veteran, plans to use the platform to find drugs that go after “undruggable” targets.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Startup offering medical second opinion service partners with Boston Children’s, Nationwide Children’s
Patients using the offering from the startup, MORE Health, can get access to physicians and services at Boston Children’s Hospital and Nationwide Children’s Hospital.
-
Creating a common language in digital therapeutics
At a workshop convening digital therapeutics companies at the DTX West meeting in San Mateo, California, stakeholders debated what was necessary to build successful business models in the industry while navigating a nascent regulatory pathway.
-
Digital health startup Klue adds diabetes feature with insulin reminders
The company, whose technology pairs with the Apple Watch and detects hand gestures, has a new feature that includes a reminder for mealtime insulin administration.
-
Chinese-American startup Terns Pharmaceuticals raises $80M for NASH, cancer drugs
The company joins a growing wave of firms developing drugs for the disease, which has no approved treatments. It expects to enter two drugs into the clinic next year.
-
Exclusive: Tuition.io adds healthcare lead to head up new vertical
Tuition.io, a startup based in Santa Monica, California, enables companies to offer a benefit that can help workers manage and repay their student loans.
-
Notable Health secures $13.5M to increase reach of wearable app for doctors
Oak HC/FT and F-Prime Capital Partners led the Series A round for the California startup, while Maverick Ventures and Greylock Partners participated.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
